MEG3 and type 2 diabetes mellitus: Our results in adipose tissue indicate that inhibition of release of PKCδI_C further reduces Gas5, while increasing the levels of Meg3 in DIO mice, suggesting a PKCδI-dependent pathway promoting the onset of type 2 diabetes in obesity.